This content is from: Banking

Cov-lite: Securitas is misleading

Market participants should not confuse investors taking substantial cov-lite risk on a high yield deal with a fully-fledged return of the risky pre-crisis lending feature, according to Barcap's Jason Meers

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial